Metabolic anti-inflammatory nanomedicines

Our proposal is to create new nanomedicines for identifying anti-inflammatory therapies.

Through the optimisation of synthetic procedures, we aim to control the primary sequence of the polymer, the size of the nanomedicine, and degradation profiles.

High-content in vitro screening will be utilised to determine which formulations can most selectively target macrophages and have the strongest anti-inflammatory effect.

To test the effectiveness of these formulations, we will collaborate with specialised research groups to conduct appropriate in vivo testing using various models of inflammation.